Related Experiment Videos
Human leukaemia associated antigen (LAA): occurrence and characteristics
Scandinavian Journal of Haematology
|November 1, 1977
Summary
Serum leukaemia-associated antigen (LAA), an oncofetal antigen, is found in leukaemia patients and occasionally healthy individuals. LAA is immunologically distinct from alpha-fetoprotein and ferritin, suggesting a unique marker for hematological disorders.
Area of Science:
- Oncoimmunology
- Hematology
- Biochemistry
Background:
- Leukaemia-associated antigen (LAA) is an oncofetal antigen found in fetal tissues and some patients with hematological disorders.
- LAA presence is not correlated with white blood cell count, and its origin in these disorders remains unclear.
- Previous research suggests potential relationships between LAA, alpha-fetoprotein, and ferritin, necessitating further clarification.
Purpose of the Study:
- To characterize the biochemical and immunological properties of serum leukaemia-associated antigen (LAA).
- To investigate the relationship between LAA and other known oncofetal antigens like alpha-fetoprotein and ferritin.
- To determine if LAA serves as a distinct marker in proliferative hematological disorders.
Main Methods:
- Protein fractionation techniques were employed to analyze LAA's molecular characteristics.
- Immunological assays, including tests for immunological non-identity, were performed.
- Antisera were generated in animals injected with leukaemia blast cells to study LAA.
Main Results:
- LAA was identified as a distinct alpha2-beta-globulin fraction, devoid of lipids.
- Immunological studies demonstrated that LAA is distinct from alpha-fetoprotein.
- Reactions of immunological non-identity were observed between LAA and ferritin, suggesting they are different molecules.
Conclusions:
- Serum LAA exhibits unique biochemical and immunological properties.
- LAA is immunologically distinct from alpha-fetoprotein and ferritin.
- Further research is needed to fully elucidate the role and origin of LAA in hematological malignancies.